Bolivia, Plurinational State of vs Montenegro: Antiretroviral therapy coverage
Bolivia, Plurinational State of
60.0%
in 2024
Montenegro
61.0%
in 2024
Bolivia, Plurinational State of rank
106th
Montenegro rank
103rd
Antiretroviral therapy coverage over time
- Bolivia, Plurinational State of
- Montenegro
How they compare
Montenegro currently reports 61.0% against 60.0% in Bolivia, Plurinational State of, a difference of 1.0%.
Across all 25 years both countries report, Montenegro has been ahead every year.
Bolivia, Plurinational State of ranks 106th and Montenegro ranks 103rd of 143 countries.
Montenegro has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.6% | 17.0% | 15.4% | Montenegro |
| 2010s | 21.5% | 36.8% | 15.3% | Montenegro |
| 2020s | 52.8% | 55.2% | 2.4% | Montenegro |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Bolivia, Plurinational State of or Montenegro?
- Montenegro, at 61.0% against 60.0% in Bolivia, Plurinational State of as of 2024.
- What is the difference in antiretroviral therapy coverage between Bolivia, Plurinational State of and Montenegro?
- 1.0%, with Montenegro ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Montenegro?
- 25 years are reported by both, from 2000 to 2024.
- How do Bolivia, Plurinational State of and Montenegro rank globally for antiretroviral therapy coverage?
- Bolivia, Plurinational State of ranks 106th and Montenegro ranks 103rd of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.